Logo Image
News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesFrom All AnglesOn Demand: WebinarsShorts
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryCURE CookbookClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer
    • Advanced Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
|Videos|June 29, 2022

Future Perspectives in Renal Cell Carcinoma (RCC)

Author(s)Thomas Hutson, DO, PharmD

Dr Thomas Hutson comments on the TiNivo-2 trial and discusses upcoming and novel therapies for patients with renal cell carcinoma.

Advertisement

Episodes in this series

EP. 1 Treatment Options for Patients with Renal Cell Carcinoma (RCC)
EP. 1 Treatment Options for Patients with Renal Cell Carcinoma (RCC)
EP. 2 Clinical Implications of the TIVO-3 Trial
EP. 2 Clinical Implications of the TIVO-3 Trial
EP. 3 Tivozanib: Adverse Event Profile and How Toxicities are Managed
EP. 3 Tivozanib: Adverse Event Profile and How Toxicities are Managed
EP. 4 Experience with Tivozanib in the 3rd Line Setting for Patients with RCC
EP. 4 Experience with Tivozanib in the 3rd Line Setting for Patients with RCC
EP. 5 Future Perspectives in Renal Cell Carcinoma (RCC)
Now Playing
EP. 5 Future Perspectives in Renal Cell Carcinoma (RCC)
Advertisement
Kidney Cancer
|
CURE Expert Connections
|
Role of Tivozanib in Renal Cell Carcinoma (RCC)

Related Content

Advertisement
The phase 3 LITESPARK-012 trial did not improve survival in advanced kidney cancer: © stock.adobe.com.

LITESPARK-012 Trial Falls Short in Advanced Kidney Cancer

ByCURE staff
April 21st 2026
Darlifarnib plus Cabometyx showed tumor responses in resistant kidney cancer: © stock.adobe.com.

Darlifarnib Combo Shows Activity in Resistant Kidney Cancer

ByCURE staff
April 17th 2026
kidney cancer survival

Progress Saved My Life From Kidney Cancer. Now We Must Keep Going.

ByChuck Stravin
April 3rd 2026
Five-year ICESECRET data show high recurrence-free rates with cryoablation for small kidney tumors: © stock.adobe.com.

Cryoablation Demonstrates Strong 5-Year Kidney Cancer Control

ByCURE staff
March 25th 2026
CURE was live on site at the the 19th Annual New York GU Cancers Congress®, where we spoke with Dr. Ulka Vaishampayan on the topic of kidney cancer.

An Introduction to the Future of Kidney Cancer Treatment

ByDr. Ulka Vaishampayan
March 13th 2026
Advertisement
Advertisement

Trending on CURE

1

Trodelvy Plus Keytruda Shows Lasting Benefit in Metastatic Breast Cancer

2

Medical Cannabis Education Improves Oncology Nurses’ Confidence in Patient Discussions

3

Changing Surveillance Routines Brings New Survivorship Challenges

4

Oncologist Answers Most Asked Questions About Colorectal Cancer

5

The Most Asked Bladder Cancer Questions: Signs, Symptoms, Stages and Treatment Options

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.